Dr. Dan Von Hoff discusses the complete phase Ib, a clinical trial approach that helps oncology biotech and pharma sponsors streamline Phase I and get to Phase II faster
•Descargar como PPT, PDF•
5 recomendaciones•1,157 vistas
A Q&A with renowned oncology investigator Dr. Daniel D. Von Hoff, M.D., who describes "the complete phase 1b," a clinical trial design that streamlines phase I by testing various drug combinations in one trial with multiple arms running in parallel.
![Welcome ,[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Recomendados
Más contenido relacionado
Último
Último (20)
Destacado
Destacado (20)
Dr. Dan Von Hoff discusses the complete phase Ib, a clinical trial approach that helps oncology biotech and pharma sponsors streamline Phase I and get to Phase II faster
- 1. The Complete Phase Ib: An Approach for Getting to Phase II Faster A Q&A with renowned oncology investigator Dr. Daniel D. Von Hoff, M.D., who describes a clinical trial design that streamlines phase I by testing various drug combinations in one trial with multiple arms running in parallel.